Skip to main content

Screening in Risk Evaluation and Prevention of Colorectal Cancer

  • Chapter
  • 839 Accesses

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States (1). In 2002, 148,000 new cases and 57,000 deaths were estimated to occur from this disease. CRC incidence and mortality rates increase with age, markedly so after age 60. Overall CRC death rates decreased by 1.8% per year from 1992 to 1998 (2); however, the death rates for CRC remain higher for African-Americans than for other ethnic groups.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Colon and rectum cancer. In Facts and Figures 2002. American Cancer Society, Atlanta, 2002:26–29.

    Google Scholar 

  2. Howe H, Wingo P, Thun M, et al. Annual report to the nation on the status of cancer (1973–1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93: 824–842.

    Article  PubMed  CAS  Google Scholar 

  3. Young GP, Rozen P, Levin B. How should we screen for early colorectal neoplasia? In Colorectal Cancer in Clinical Practice: Prevention, Early Detection and Management Rozen P, Young G, Levin B, Spann S, eds. Martin Dunitz, Ltd, London, 2002; pp. 77–99.

    Google Scholar 

  4. Gatof D, Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin North Am 2002;31: 587–623.

    Article  PubMed  Google Scholar 

  5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;278:1365–1372.

    Article  Google Scholar 

  6. Hardcastle JD, Chamberlain JD, Robinson NHI, et al. Randomized controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472–1477.

    Article  PubMed  CAS  Google Scholar 

  7. Kronborg O, Fenger C, Olsen J, et al. Randomized study of screening for colorectal cancer with fecal-occult blood test. Lancet 1996;348:1467–1471.

    Article  PubMed  CAS  Google Scholar 

  8. Jorgensen OD, Kronborg O, Fenger C, et al. A randomized study of screening for colorectal cancer using faecal occult blood testing. Results after 13 years and 7 biennial screening rounds. Gut 2002; 50:29–32.

    Article  PubMed  CAS  Google Scholar 

  9. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2002;2:CD001216.

    Google Scholar 

  10. Selby JV, Fredman GD, Quesenbery CP Jr, et al. A case control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653–657.

    PubMed  CAS  Google Scholar 

  11. Kavanagh AM, Giovannucci E, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998;9: 455–461.

    Article  PubMed  CAS  Google Scholar 

  12. Thiis-Evenson E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414–420.

    Article  Google Scholar 

  13. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:2735–3095.

    Google Scholar 

  14. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicenter randomized trial. Lancet 2002;359:1291–1300.

    Article  Google Scholar 

  15. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. VA Cooperative Study Group 380. N Engl J Med 2000;343:162–168.

    Article  PubMed  CAS  Google Scholar 

  16. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 334: 169–174.

    Article  Google Scholar 

  17. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1997–1981.

    Article  Google Scholar 

  18. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Intern Med 1995; 23:904–910.

    Google Scholar 

  19. Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48: 812–815.

    Article  PubMed  CAS  Google Scholar 

  20. Jorgensen OD, Kronborg O, Fenger C. The Funen adenoma follow-up study: incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993;28:869–871.

    Article  PubMed  CAS  Google Scholar 

  21. Cash B, Schoenfeld PS, Dobhan R, et al. Colorectal neoplasia screening with colonoscopy in asymptomatic women at regional naval medical centers. Gastroenterology 2001;120:A509.

    Google Scholar 

  22. Winawer SJ, Zauber AG, Church TR, et al. National Colonoscopy Study (NCS) Preliminary Results: a randomized controlled trial of general population screening colonoscopy. Gastroenterology 2002;122:T-1560.

    Google Scholar 

  23. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000;342: 1766–1772.

    Article  PubMed  CAS  Google Scholar 

  24. Smith RA, Cokkinides V, Von Eschenbach AC, et al. American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin 2002;52:8–22.

    Article  PubMed  Google Scholar 

  25. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: guidelines and rationale. Gastroenterology 1997;112:594–642.

    Article  PubMed  CAS  Google Scholar 

  26. Screening for colorectal cancer: rcommendation and rationale. US Preventive Services Task Force. Ann Intern Med 2002;129–131.

    Google Scholar 

  27. Trends in screening for colorectal cancer—United States 1997 and 1999. JAMA 2001;295:1570–1571.

    Google Scholar 

  28. Spann S, Rozen P, Levin B, Young G. The pros and cons of population-based colorectal cancer preventative strategies. In Colorectal Cancer in Clinical Practice: Prevention, Early Detection and Management Rozen P, Young G, Levin B, Spann S, eds. Martin Dunitz Ltd, London, 2002;10: pp. 115–129.

    Google Scholar 

  29. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102–105.

    Article  PubMed  CAS  Google Scholar 

  30. Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 2002;315:157–168.

    Article  PubMed  CAS  Google Scholar 

  31. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA of patients with colorectal tumors. N Engl J Med 2002;346:311–320.

    Article  PubMed  CAS  Google Scholar 

  32. Traverso G, Shuber A, Olsson L, et al. Detection of proximal colorectal cancer through the analysis of faecal DNA. Lancet 2002;359:403–404.

    Article  PubMed  CAS  Google Scholar 

  33. Fletcher JG, Johnson CD, Welch TJ, et al. Optimization of CT colonography technique: prospective trial in 180 patients. Radiology 2000;216:704–711.

    PubMed  CAS  Google Scholar 

  34. Gluecker T, Dorta G, Keller W, et al. Performance of multidetection computed tomography colonography compared with conventional colonoscopy. Gut 2002;51:207–211.

    Article  PubMed  Google Scholar 

  35. Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal cancer and adenomatous polyps: a framework for action—the strategic plan of the National Colorectal Cancer Roundtable. Cancer 2002;95: 1618–1628.

    Article  PubMed  Google Scholar 

  36. Selby JV. Colorectal cancer screening: keeping the options open. Eff Clin Pract 2001;4:39–41.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Levin, B. (2005). Screening in Risk Evaluation and Prevention of Colorectal Cancer. In: Kelloff, G.J., Hawk, E.T., Sigman, C.C. (eds) Cancer Chemoprevention. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-59259-768-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-768-0_21

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-077-9

  • Online ISBN: 978-1-59259-768-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics